A novel mutation in ORAI1 presenting with combined immunodeficiency and residual T-cell function
This work was supported by the National Institutes of Health (grants T32 HD43029 and T32
AI7062 provided support for TM during his fellowship training at Duke University Medical
Center) and a Clinical Immunology Society/Grifols Senior Fellowship Award (to TM). The
collection of control samples and the production of sequence data were funded in part by the
National Institute of Allergy and Infectious Diseases (NIAID) grant UO1AIO67854 (Center for
HIV/AIDS Vaccine Immunology [''CHAVI'']). Disclosure of potential conflict of interest: T …
AI7062 provided support for TM during his fellowship training at Duke University Medical
Center) and a Clinical Immunology Society/Grifols Senior Fellowship Award (to TM). The
collection of control samples and the production of sequence data were funded in part by the
National Institute of Allergy and Infectious Diseases (NIAID) grant UO1AIO67854 (Center for
HIV/AIDS Vaccine Immunology [''CHAVI'']). Disclosure of potential conflict of interest: T …